Viewing Study NCT00866320


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2025-12-26 @ 3:20 AM
Study NCT ID: NCT00866320
Status: COMPLETED
Last Update Posted: 2014-07-23
First Post: 2009-03-19
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab
Sponsor: Case Comprehensive Cancer Center
Organization: